ArticleInternal medicine (Tokyo, Japan)2018

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment.

Takeshi Hirayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.